{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:12:05Z","timestamp":1790107925574,"version":"4.0.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113818","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T01:15:50Z","timestamp":1630631750000},"page":"113818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities"],"prefix":"10.1016","volume":"225","author":[{"given":"Xiao Bao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113818_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2021.113818_bib2","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1200470109","article-title":"NSP4, an elastase-related protease in human neutrophils with arginine specificity","volume":"109","author":"Perera","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113818_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V92.4.1415","article-title":"On the role of the proform-conformation for processing and intracellular sorting of human cathepsin G","volume":"92","author":"Garwicz","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2021.113818_bib4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1172\/JCI200419062","article-title":"Mast cell dipeptidyl peptidase I mediates survival from sepsis","volume":"113","author":"Mallen","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113818_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1074\/jbc.RA118.004376","article-title":"Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin","volume":"294","author":"John","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/cbin.10815","article-title":"The regulatory role of Dipeptidyl peptidase I on the activation of immune granulocytes","volume":"41","author":"Chu","year":"2017","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ejmech.2021.113818_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.2010080892","article-title":"Neutrophil serine proteases promote IL-1beta generation and injury in necrotizing crescentic glomerulonephritis","volume":"23","author":"Schreiber","year":"2012","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2021.113818_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2021.113818_bib9","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1074\/jbc.M115.707109","article-title":"Neutrophilic cathepsin C is maturated by a multistep proteolytic process and secreted by activated cells during inflammatory lung diseases","volume":"291","author":"Hamon","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib10","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1021\/acs.jmedchem.0c00776","article-title":"Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS?","volume":"63","author":"Korkmaz","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib11","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1093\/emboj\/20.23.6570","article-title":"Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases","volume":"20","author":"Turk","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2021.113818_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0014-5793(95)00777-7","article-title":"Molecular cloning and sequence analysis of human preprocathepsin C","volume":"369","author":"Paris","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2021.113818_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0021-9258(18)57294-X","article-title":"On the proteolytic enzymes of animal tissues; an intracellular enzyme related to chymotrypsin","volume":"174","author":"Gutmann","year":"1948","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0006-3002(61)90469-3","article-title":"Specificity of cathepsin C","volume":"53","author":"Planta","year":"1961","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113818_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-291X(72)90630-4","article-title":"Detection of a lysosomal carboxypeptidase and a lysosomal dipeptidase in highly-purified dipeptidyl aminopeptidase I (cathepsin C) and the elimination of their activities from preparations used to sequence peptides","volume":"46","author":"McDonald","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2021.113818_bib16","first-page":"511","article-title":"The catalytic properties OF cathepsin C","volume":"89","author":"Planta","year":"1964","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113818_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0076-6879(72)25024-8","article-title":"Preparation and specificity of dipeptidyl aminopeptidase I","volume":"25","author":"McDonald","year":"1972","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2021.113818_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0021-9258(18)65871-5","article-title":"Specificity of cathepsin C","volume":"218","author":"Izumiya","year":"1956","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00285511","article-title":"Cathepsin C activity as related to some histochemical substrates","volume":"5","author":"Vanha-Perttula","year":"1965","journal-title":"Histochemie"},{"key":"10.1016\/j.ejmech.2021.113818_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0003-9861(92)90519-3","article-title":"Purification and characterization of dipeptidyl peptidase I from human spleen","volume":"295","author":"McGuire","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2021.113818_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI0213462","article-title":"Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis","volume":"109","author":"Adkison","year":"2002","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2021.113818_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/BJ20061389","article-title":"The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2","volume":"401","author":"Molgaard","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113818_bib23","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.96.15.8627","article-title":"Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in\u00a0vivo","volume":"96","author":"Pham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113818_bib24","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.150.11.4733","article-title":"Dipeptidyl peptidase I is enriched in granules of in\u00a0vitro- and in\u00a0vivo-activated cytotoxic T lymphocytes","volume":"150","author":"Brown","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113818_bib25","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1074\/jbc.272.16.10695","article-title":"Molecular cloning, chromosomal localization, and expression of murine dipeptidyl peptidase I","volume":"272","author":"Pham","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib26","doi-asserted-by":"crossref","first-page":"20836","DOI":"10.1074\/jbc.M702615200","article-title":"Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing","volume":"282","author":"Methot","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1432-1033.1994.tb19018.x","article-title":"Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C)","volume":"223","author":"Nauland","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2021.113818_bib28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0006-3002(63)91067-9","article-title":"Prothrombin activation with cathepsin C","volume":"78","author":"Purcell","year":"1963","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2021.113818_bib29","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1074\/jbc.272.15.10260","article-title":"Human dipeptidyl-peptidase I. Gene characterization, localization, and expression","volume":"272","author":"Rao","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib30","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/S0021-9258(18)53798-4","article-title":"Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I","volume":"268","author":"McGuire","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib31","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.4049\/jimmunol.160.12.5880","article-title":"Dipeptidyl peptidase I and granzyme A are coordinately expressed during CD8+ T cell development and differentiation","volume":"160","author":"Mabee","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113818_bib32","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/bi001693z","article-title":"Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing","volume":"40","author":"Dahl","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113818_bib33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1078\/0171-9335-00291","article-title":"Importance of the propeptide in the biosynthetic maturation of rat cathepsin C","volume":"81","author":"Santilman","year":"2002","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejmech.2021.113818_bib34","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3390\/ijms20194747","article-title":"Processing and maturation of cathepsin C zymogen: a biochemical and molecular modeling analysis","volume":"20","author":"Lamort","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113818_bib35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1515\/BC.2006.141","article-title":"Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice","volume":"387","author":"Mallen-St Clair","year":"2006","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2018.05.011","article-title":"Therapeutic targeting of cathepsin C: from pathophysiology to treatment","volume":"190","author":"Korkmaz","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113818_bib37","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1021\/bi8007627","article-title":"Chemical mechanism of a cysteine protease, cathepsin C, as revealed by integration of both steady-state and pre-steady-state solvent kinetic isotope effects","volume":"47","author":"Schneck","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113818_bib38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00726-013-1654-2","article-title":"Unnatural amino acids increase activity and specificity of synthetic substrates for human and malarial cathepsin C","volume":"46","author":"Poreba","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.ejmech.2021.113818_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/70525","article-title":"Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis","volume":"23","author":"Toomes","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2021.113818_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/jmg.37.2.88","article-title":"Haim-Munk syndrome and Papillon-Lefevre syndrome are allelic mutations in cathepsin C","volume":"37","author":"Hart","year":"2000","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmech.2021.113818_bib41","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1074\/jbc.RA118.001922","article-title":"Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis","volume":"293","author":"Seren","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.5A1015-489R","article-title":"Characterization of neutrophil function in Papillon-Lefevre syndrome","volume":"100","author":"Roberts","year":"2016","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.ejmech.2021.113818_bib43","doi-asserted-by":"crossref","first-page":"18551","DOI":"10.1074\/jbc.M100223200","article-title":"Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice","volume":"276","author":"Wolters","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib44","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.180.5.3535","article-title":"Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to Sendai virus infection","volume":"180","author":"Akk","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113818_bib45","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2217\/14796678.3.6.591","article-title":"Role of cathepsin C in elastase-induced mouse abdominal aortic aneurysms","volume":"3","author":"Shi","year":"2007","journal-title":"Future Cardiol."},{"key":"10.1016\/j.ejmech.2021.113818_bib46","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1073\/pnas.0606091104","article-title":"Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms","volume":"104","author":"Pagano","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2021.113818_bib47","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/ATVBAHA.116.307786","article-title":"Neutrophil proteases promote experimental abdominal aortic aneurysm via extracellular trap release and plasmacytoid dendritic cell activation","volume":"36","author":"Yan","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejmech.2021.113818_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.actatropica.2019.04.018","article-title":"Toxoplasma gondii Cathepsin C1 inhibits NF-kappaB signalling through the positive regulation of the HIF-1alpha\/EPO axis","volume":"195","author":"Liu","year":"2019","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2021.113818_bib49","doi-asserted-by":"crossref","first-page":"982","DOI":"10.33594\/000000190","article-title":"Inflammatory serine proteases play a critical role in the early pathogenesis of diabetic cardiomyopathy","volume":"53","author":"Kolpakov","year":"2019","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2021.113818_bib50","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1038\/s41598-019-46206-8","article-title":"Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation","volume":"9","author":"Rehm","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113818_bib51","doi-asserted-by":"crossref","first-page":"118723","DOI":"10.1016\/j.bbamcr.2020.118723","article-title":"Cathepsin C is a novel mediator of podocyte and renal injury induced by hyperglycemia","volume":"1867","author":"Audzeyenka","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ejmech.2021.113818_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-2094-9-96","article-title":"Up-regulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation","volume":"9","author":"Fan","year":"2012","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.ejmech.2021.113818_bib53","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/ejn.12096","article-title":"Differences in expression patterns of cathepsin C\/dipeptidyl peptidase I in normal, pathological and aged mouse central nervous system","volume":"37","author":"Koike","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113818_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11064-017-2320-y","article-title":"Cathepsin C aggravates neuroinflammation involved in disturbances of behaviour and neurochemistry in acute and chronic stress-induced murine model of depression","volume":"43","author":"Zhang","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2021.113818_bib55","doi-asserted-by":"crossref","first-page":"105107","DOI":"10.1016\/j.neuint.2021.105107","article-title":"Cathepsin C aggravates neuroinflammation via promoting production of CCL2 and CXCL2 in glial cells and neurons in a cryogenic brain lesion","volume":"148","author":"Zhao","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejmech.2021.113818_bib56","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4161\/cc.3.12.1289","article-title":"Multiple roles for cysteine cathepsins in cancer","volume":"3","author":"Joyce","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2021.113818_bib57","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1101\/gad.1407406","article-title":"Distinct roles for cysteine cathepsin genes in multistage tumorigenesis","volume":"20","author":"Gocheva","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2021.113818_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4161\/cc.6.1.3669","article-title":"Cysteine cathepsins and the cutting edge of cancer invasion","volume":"6","author":"Gocheva","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2021.113818_bib59","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1101\/gad.224899.113","article-title":"Cathepsin C is a tissue-specific regulator of squamous carcinogenesis","volume":"27","author":"Ruffell","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2021.113818_bib60","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellsig.2018.02.017","article-title":"Targeting of cathepsin C induces autophagic dysregulation that directs ER stress mediated cellular cytotoxicity in colorectal cancer cells","volume":"46","author":"Khaket","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2021.113818_bib61","doi-asserted-by":"crossref","first-page":"13332","DOI":"10.1002\/jcp.28010","article-title":"Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT\/miR-129-5p axis","volume":"234","author":"Chiang","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2021.113818_bib62","article-title":"Praeruptorin B mitigates the metastatic ability of human renal carcinoma cells through targeting CTSC and CTSV expression","volume":"21","author":"Lin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113818_bib63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4143\/crt.2019.145","article-title":"Cathepsin C interacts with TNF-alpha\/p38 MAPK signaling pathway to promote proliferation and metastasis in hepatocellular carcinoma","volume":"52","author":"Zhang","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ejmech.2021.113818_bib64","doi-asserted-by":"crossref","first-page":"105156","DOI":"10.1016\/j.phrs.2020.105156","article-title":"In\u00a0vitro and in\u00a0vivo studies on potentiation of curcumin-induced lysosomal-dependent apoptosis upon silencing of cathepsin C in colorectal cancer cells","volume":"161","author":"Khaket","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113818_bib65","first-page":"1304","article-title":"Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C","volume":"11","author":"Kim","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.ejmech.2021.113818_bib66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Canc. Cell"},{"key":"10.1016\/j.ejmech.2021.113818_bib67","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0003-2697(63)90088-5","article-title":"A\u00a0simple estimation of cathepsin C using a new chromogenic substrate","volume":"5","author":"Planta","year":"1963","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2021.113818_bib68","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0021-9258(19)69895-9","article-title":"Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases","volume":"256","author":"Green","year":"1981","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0162-3109(00)00267-8","article-title":"Dipeptide vinyl sulfones suitable for intracellular inhibition of dipeptidyl peptidase I","volume":"1","author":"Korver","year":"2001","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2021.113818_bib70","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.158.11.5200","article-title":"A\u00a0selective inhibitor of dipeptidyl peptidase I impairs generation of CD8+ T cell cytotoxic effector function","volume":"158","author":"Thiele","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ejmech.2021.113818_bib71","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1021\/jm00151a018","article-title":"Carboxyl-modified amino acids and peptides as protease inhibitors","volume":"29","author":"Thompson","year":"1986","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib72","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.abb.2004.04.011","article-title":"Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C)","volume":"427","author":"Kam","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2021.113818_bib73","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1016\/j.bmcl.2006.01.102","article-title":"Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors","volume":"16","author":"Bondebjerg","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113818_bib74","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1016\/j.bmcl.2009.07.114","article-title":"Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C","volume":"19","author":"Guay","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113818_bib75","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1124\/mol.108.045682","article-title":"In\u00a0vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C","volume":"73","author":"Methot","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113818_bib76","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/jm401705g","article-title":"Cathepsin C inhibitors: property optimization and identification of a clinical candidate","volume":"57","author":"Furber","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib77","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1111\/bph.13515","article-title":"Neutrophil maturation rate determines the effects of dipeptidyl peptidase 1 inhibition on neutrophil serine protease activity","volume":"173","author":"Gardiner","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113818_bib78","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1021\/acs.chemrestox.5b00236","article-title":"Aortic binding of AZD5248: mechanistic insight and reactivity assays to support lead optimzation","volume":"28","author":"Bragg","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113818_bib79","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/acs.jmedchem.6b01127","article-title":"Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)","volume":"59","author":"Doyle","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib80","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","volume":"104","author":"Palmer","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2021.113818_bib81","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113818_bib82","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0968-0896(02)00173-6","article-title":"Peptidic 1-cyanopyrrolidines: synthesis and SAR of a series of potent, selective cathepsin inhibitors","volume":"10","author":"Rydzewski","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib83","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1021\/jm0003440","article-title":"Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L","volume":"44","author":"Falgueyret","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib84","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/ml100212k","article-title":"Discovery of novel cyanamide-based inhibitors of cathepsin C","volume":"2","author":"Laine","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113818_bib85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bcp.2017.02.009","article-title":"Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases","volume":"131","author":"Guarino","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113818_bib86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bcp.2019.04.006","article-title":"Structure-based design and in\u00a0vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C","volume":"164","author":"Korkmaz","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113818_bib87","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1111\/bcp.13398","article-title":"Epithelial desquamation observed in a phase I study of an oral cathepsin C inhibitor (GSK2793660)","volume":"83","author":"Miller","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113818_bib88","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1016\/j.bmc.2005.04.048","article-title":"Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI)","volume":"13","author":"Bondebjerg","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj2010189","article-title":"L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L","volume":"201","author":"Barrett","year":"1982","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.113818_bib90","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/cmdc.201300093","article-title":"E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors","volume":"8","author":"Radzey","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113818_bib91","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1046\/j.1432-1327.2000.01364.x","article-title":"Arginine-based structures are specific inhibitors of cathepsin C. Application of peptide combinatorial libraries","volume":"267","author":"Horn","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2021.113818_bib92","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.bmcl.2004.04.028","article-title":"Synthesis and activity of phosphinic tripeptide inhibitors of cathepsin C","volume":"14","author":"Mucha","year":"2004","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113818_bib93","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.biochi.2013.05.006","article-title":"Toward very potent, non-covalent organophosphonate inhibitors of cathepsin C and related enzymes by 2-amino-1-hydroxy-alkanephosphonates dipeptides","volume":"95","author":"Drag","year":"2013","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2021.113818_bib94","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1021\/acs.jmedchem.9b00631","article-title":"Identification and optimization of novel cathepsin C inhibitors derived from EGFR inhibitors","volume":"62","author":"Hou","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113818_bib95","doi-asserted-by":"crossref","first-page":"10225","DOI":"10.1039\/C6CC04030F","article-title":"Focusing on probe-modified peptides: a quick and effective method for target identification","volume":"52","author":"Sun","year":"2016","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.ejmech.2021.113818_bib96","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.biopha.2017.09.139","article-title":"Inhibitory effect of Triperygium wilfordii polyglucoside on dipeptidyl peptidase I in\u00a0vivo and in\u00a0vitro","volume":"96","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2021.113818_bib97","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in\u00a0vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","author":"Chen","year":"2021","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342100667X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342100667X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:36:04Z","timestamp":1759329364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342100667X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":97,"alternative-id":["S022352342100667X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113818","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathepsin C inhibitors as anti-inflammatory drug discovery: Challenges and opportunities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113818"}}